Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Dinesh_V._Patel
|
| gptkbp:collaboratesWith |
gptkb:Janssen_Biotech
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developsDrug |
gptkb:JNJ-2113
gptkb:rusfertide |
| gptkbp:focusesOn |
peptide-based therapeutics
|
| gptkbp:foundedYear |
2006
|
| gptkbp:headquartersLocation |
gptkb:Newark,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Protagonist Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:specializesIn |
rare diseases
gastrointestinal diseases hematological diseases |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:PTGX
|
| gptkbp:website |
https://www.protagonist-inc.com/
|
| gptkbp:bfsParent |
gptkb:Wende_Hutton
|
| gptkbp:bfsLayer |
7
|